| Revenue | DKK 1,7M | +2955% |
| EBITDA | DKK 227K | +2148% |
| Net profit | DKK 137K | +361% |
| Total assets | DKK 1,5M | +956% |
| Equity | DKK 1,1M | +3863% |
| Employees | 9 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | -11 | 34 | 147 | 39 | 56 | 1.704 |
| Staff expenses | -31 | -13 | -110 | -5 | -67 | -1.477 |
| EBITDA | -42 | 20 | 38 | 34 | -11 | 227 |
| Depreciation & amort. | -4 | -53 | -53 | -53 | -53 | -53 |
| EBIT | -46 | -33 | -15 | -18 | -64 | 174 |
| Net financials | -2 | -7 | -2 | -2 | -2 | 4 |
| Profit before tax | -48 | -40 | -17 | -20 | -66 | 178 |
| Tax | -10 | -7 | 16 | -5 | -14 | 41 |
| Net profit | -38 | -33 | -33 | -15 | -52 | 137 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 356 | 305 | 354 | 179 | 142 | 1.500 |
| Equity | 162 | 129 | 97 | 81 | 29 | 1.146 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 194 | 176 | 258 | 98 | 113 | 335 |
| Total debt | 194 | 176 | 258 | 98 | 113 | 335 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Zimplifi Holding ApS | Company | 33.3% | 33.3% | 2024 |
Heinmann AI Holding ApS | Company | 33.3% | 33.3% | 2024 |
Kollhoff Kapital ApS | Company | 25.0% | 25.0% | 2024 |
| Individual | 5.0% | 5.0% | 2020 | |
Apidemia IVS | Company | 20.0% | 20.0% | 2020 |
| Person | Role here | Other companies |
|---|---|---|
| Sara Schøler Lass | Management | 0 companies |
| Carsten Heinmann | Board of Directors | 0 companies |
| Mette Kollhoff | Board of Directors | 0 companies |